Dow Jones

40 003,59

0,34%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Frazier LifeSciences Acquisition Corporation (FLAC)
Frazier LifeSciences Acquisition Corporation (FLAC) Actualités

FLAC

Frazier LifeSciences Acq... (FLAC)

Frazier LifeSciences Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:FLAC

Date	Heure	Source	Titre	Symbole	Société
15/02/2023	16h15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
02/12/2022	22h32	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
25/11/2022	19h44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
23/11/2022	22h37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
23/11/2022	22h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
23/11/2022	14h00	GlobeNewswire Inc.	NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
22/11/2022	22h17	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
15/11/2022	17h31	Business Wire	Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
15/11/2022	00h13	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
09/11/2022	22h07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
13/10/2022	23h02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
26/09/2022	14h00	GlobeNewswire Inc.	Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
25/07/2022	14h00	Business Wire	NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
25/03/2022	22h18	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
14/02/2022	23h08	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
31/01/2022	22h44	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
31/01/2022	22h41	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation
17/05/2021	22h04	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:FLAC	Frazier LifeSciences Acquisition Corporation